NCT01596530View on ClinicalTrials.gov

Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Breast Neoplasm
Interventions
DRUG

Drug-AZD8931

Active drug for biological activity

DRUG

Drug-Placebo

Placebo comparator for biological activity comparison

Trial Locations (7)

Unknown

Research Site, Düsseldorf

Research Site, Essen

Research Site, Wittenberg

Research Site, Seoul

Research Site, Yonsei

Research Site, Taichung

Research Site, Taipei

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY